New and Upcoming Products Featured in the Q2 2026 Antiretrovirals (HIV) Market Review

Gilead worked to differentiate Biktarvy from competitors with a new campaign, announced regulatory updates for Yeztugo and a new STR, along with a website for the new combination, and launched an unbranded educational initiative.

Merck highlighted key Idvynso developments, including its approval, an access agreement, and study data presentations.